1-4 of 4
Scott D. Berkowitz, MD, FACP
Close
Sort by
Journal Articles

Quantitative Benefit–Risk Assessment of Rivaroxaban for the Prevention of Venous Thromboembolism.

Bennett Levitan, MD, PhD, Zhong Yuan, MD, PhD, Alexander GG Turpie, MD, Richard J Friedman, MD, Martin Homering, MSPH, Jesse A Berlin, ScD, Scott D Berkowitz, MD, FACP, Peter M DiBattiste, MD, FACC
Journal: Blood
Blood (2009) 114 (22): 169.
https://doi.org/10.1182/blood.V114.22.169.169
Published: 2009
Journal Articles

Prothrombin Time and Bleeding Events in Patients Undergoing Total Hip or Knee Replacement Surgery Receiving 10 Mg Rivaroxaban.

Sylvia Haas, MD, Alexander GG Turpie, MD, Michael Rud Lassen, MD, Ajay K Kakkar, MD, PhD, Bengt Eriksson, MD, PhD, Kai Vogtlaender, Dagmar Kubitza, MD, Wolfgang Mueck, PhD, Michael Gent, DSc, Frank Misselwitz, MD, Scott D Berkowitz, MD, FACP
Journal: Blood
Blood (2009) 114 (22): 2099.
https://doi.org/10.1182/blood.V114.22.2099.2099
Published: 2009
Journal Articles

Once-Daily Oral Rivaroxaban Compared with Subcutaneous Enoxaparin Every 12 Hours for Thromboprophylaxis after Total Knee Replacement: RECORD4

Alexander GG Turpie, MD, Kenneth A. Bauer, MD, Bruce Davidson, MD, Michael Gent, MD, Louis Kwong, MD, Michael Rud Lassen, MD, Fred Cushner, MD, Paul Lotke, MD, Scott D. Berkowitz, MD, FACP, Tiemo Joerg Bandel, Frank Misselwitz, MD, William Fisher, MD
Journal: Blood
Blood (2008) 112 (11): 35.
https://doi.org/10.1182/blood.V112.11.35.35
Published: 2008
Journal Articles

Effects of Age, Weight, Gender and Renal Function in a Pooled Analysis of Four Phase III Studies of Rivaroxaban for Prevention of Venous Thromboembolism after Major Orthopedic Surgery

Kenneth A. Bauer, MD, Martin Homering, Scott D. Berkowitz, MD, FACP
Journal: Blood
Blood (2008) 112 (11): 436.
https://doi.org/10.1182/blood.V112.11.436.436
Published: 2008